Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 19 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-05-08 | 2019-06-24 | 83504 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-05-15 | 2019-06-24 | 84159 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-06-05 | 2019-06-21 | 85619 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-07-03 | 2019-08-03 | 88336 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-21 | 2019-09-16 | 92019 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-21 | 2019-08-30 | 92026 |
APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-25 | 2019-11-04 | 94734 |
APO-CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-10-02 | 2021-07-15 | 95266 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-10-16 | 2019-11-18 | 96647 |
APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-27 | 2020-03-02 | 99792 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-05 | 2021-05-03 | 100281 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-05 | 2023-07-04 | 100284 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-04 | 2020-08-17 | 116542 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-24 | 2020-08-17 | 118766 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-08 | 2020-07-18 | 119759 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-08-07 | 121322 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-29 | 2020-07-30 | 121325 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-06 | 2020-09-04 | 121903 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-26 | 2020-09-02 | 122994 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 |